WHO

This document provides guidance on monitoring and evaluating the implementation of the comprehensive package of interventions to address HIV among key populations: men who have sex with men, people in prisons and other closed settings, people who inject drugs, sex workers and transgender people.

This document provides countries with:

• a set of harmonized indicators to examine the implementation of the package of interventions to address HIV among key populations; and
• guidance on setting targets for these indicators.

This document updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 2016. It is being published in a changing global context for HIV and for health more broadly.

The purpose of this framework is to provide operational guidance on monitoring and evaluation of pregnant and breastfeeding women receiving ART for life and their HEIs. This document is organized around a series of recommendations for the operationalization of monitoring, both routine (Section 1) and enhanced (Section 2), and the evaluation (Section 3) of programmes implementing lifelong ART for pregnant and breastfeeding women and their infants.

The new Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings). They present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines.

This document puts forward a framework with new strategic directions for 2016–2021 on voluntary medical male circumcision (VMMC) for HIV prevention as the follow-on to the Joint Strategic Action Framework 2012–2016. The new directions focus on adolescent boys and men, and take into account a range of physical and psychosocial health issues. They highlight the need for innovative approaches to overcome current barriers to services, increase acceptability, and address inequalities in access and coverage. This document will be used to inform, both regionally and globally, an action-oriented and operational framework on VMMC and men’s health, with overlapping benefits for women’s health.

The IMCI chart booklet is for use by doctors, nurses and other health professionals who see young infants and children less than five years old. It facilitates the use of the IMCI case management process in practice and describes a series of all the case management steps in a form of IMCI charts. 

These charts show the sequence of steps and provide information for performing them. The IMCI chart booklet should be used by all health professionals providing care to sick children to help them apply the IMCI case management guidelines. Health professionals should always use the chart booklet for easy reference. 

The chart booklet is divided into two main parts because clinical signs in sick young infants (up to 2 months) and older children (2 months to 5 years) are somewhat different and because case management procedures also differ between these age groups.

In 2014, only 50% of all HIV-exposed infants were tested by the second month of age. Innovative approaches such as use of assays at the point-of care and adding virological testing at birth could speed up identification and ART initiation. Operational research to fully inform how to implement such innovations remains critical.

This document is written for national HIV surveillance programme staff responsible for monitoring trends in country HIV epidemics. Its purpose is to describe how routine prevention of mother-to-child transmission of HIV (PMTCT) programme data can be used to conduct HIV surveillance among pregnant women attending antenatal clinics (ANC). These guidelines assume that surveillance programmes have already assessed the readiness of routine programme data to be used for surveillance. WHO’s 2013 Guidelines for assessing the utility of prevention of mother-to-child transmission (PMTCT) programme data for HIV sentinel surveillance among pregnant women describes these assessment methods.